Evaluation of Pax5 expression and comparison with BLA.36 and CD79αcy in feline non-Hodgkin lymphoma

Vet Comp Oncol. 2017 Dec;15(4):1257-1268. doi: 10.1111/vco.12262. Epub 2016 Aug 22.

Abstract

Paired box gene 5 (Pax5) is a widely used B-cell marker for human and canine non-Hodgkin's lymphoma (nHL); however, in the literature there is only one case report using Pax5 in a cat B-cell lymphoma. The purposes of this study were to investigate the expression and detection of B-cell specific activator protein (BSAP) using a monoclonal anti-Pax5 antibody in feline nHL (FnHL) tissue samples to evaluate its diagnostic relevance as a B-cell marker. A total of 45 FnHL samples in 45 cats were evaluated. B-cell lymphoma was the most common immunophenotype (51.1%) for all the samples and T-cell the most common immunophenotype (64.3%) for the gastrointestinal (GI) form. Pax5 stained 82.6% of all B-cell lymphomas and no expression was found in any of the T-cell lymphomas. Anti-Pax5 antibody staining in FnHL is similar to that reported in human and canine counterparts and may offer an excellent B-cell marker in cats.

Keywords: Pax5; expression; feline non-Hodgkin lymphoma; immunohistochemistry.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antigens, Neoplasm / metabolism*
  • Biomarkers, Tumor / metabolism
  • CD3 Complex / metabolism
  • CD79 Antigens / metabolism*
  • Cat Diseases / metabolism*
  • Cats
  • Female
  • Lymphoma, Non-Hodgkin / metabolism
  • Lymphoma, Non-Hodgkin / veterinary*
  • Lymphoma, T-Cell / metabolism
  • Lymphoma, T-Cell / veterinary
  • Male
  • PAX5 Transcription Factor / metabolism*

Substances

  • Antigens, Neoplasm
  • Biomarkers, Tumor
  • CD3 Complex
  • CD79 Antigens
  • PAX5 Transcription Factor